Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

Apr 1, 2014 (Vol. 34, No. 7)

Fighting Kidney Toxicity: The Case for Better Biomarkers

  • Burdened with the demands of handling waste, the kidneys are particularly susceptible to drug-induced toxicity. So it’s no surprise that pharma companies are increasingly ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »